CoChat

Conventional and Nuclear Medicine Imaging in Ectopic Cushing's Syndrome: A Systematic Review

Open access
Isidori, Andrea M., Sbardella, Emilia, Zatelli, Maria Chiara, Boschetti, Mara, Vitale, Giovanni, Colao, Annamaria, Pivonello, Rosario, * ABC (Altogether to Beat Cushing's syndrome) 2013 Group collaborators, Albiger, N., Ambrogio, A., Arnaldi, G., Arvat, E., Berardelli, R., Boscaro, M., Boschetti, M., Cannavò, S., Cavagnini, F., Colao, A., Corsello, S. M., Cozzolino, A., De Leo, M., Di Somma, C., Esposito, K., Ferone, D., Foresta, C., Gatto, F., Giordano, C., Giugliano, D., Graziadio, C., Isidori, A. M., Loli, P., Manetti, L., Mannelli, M., Marzullo, P., Mantero, F., Minuto, F., Paragliola, R. M., Giraldi, F. Pecori, Pivonello, R., Reimondo, G., Scaroni, C., Scillitani, A., Simeoli, C., Stigliano, A., Terzolo, M., Tortora, F., Trementino, L., Vitale, G., Zatelli, M. C. · 2015 · The Journal of Clinical Endocrinology & Metabolism
Cited by 150

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

CONTEXT: Ectopic Cushing's Syndrome (ECS) can be a diagnostic challenge with the hormonal source difficult to find. This study analyzes the accuracy of imaging studies in ECS localization. EVIDENCE ACQUISITION: Systematic review of medical literature for ECS case series providing individual patient data on at least one conventional imaging technique (computed tomography [CT]/magnetic resonance imaging) and one of the following: 111In-pentetreotide (OCT), 131I/123I-metaiodobenzylguanidine, 18Ffluoro-2-deoxyglucose-positron emission tomography (FDG-PET), 18F-fluorodopa-PET (F-DOPA-PET), 68Ga- DOTATATE-PET/CT or 68Ga-DOTATOC-PET/CT scan (68Gallium-SSTR-PET/CT). EVIDENCE SUMMARY: The analysis comprised 231 patients (females, 50.2%; age, 42.617 y). Overall, 52.4%(121/231) had "overt" ECS,18.6% had "occult" ECS, and 29% had "covert" ECS. Tumors were located in the lung (55.3%), mediastinum-thymus (7.9%), pancreas (8.5%), adrenal glands (6.4%), gastrointestinal tract (5.4%), thyroid (3.7%), and other sites (12.8%), and primary tumors were mostly bronchial neuroendocrine tumors (NETs) (54.8%), pancreatic NETs (8%), mediastinum-thymus NETs (6.9%), gastrointestinal NETs (5.3%), pheochromocytoma (6.4%), neuroblastoma (3.2%), and medullary thyroid carcinoma (3.2%). Tumors were localized byCTin66.2%(137/207), magnetic resonance imaging in 51.5% (53/103), OCT in 48.9% (84/172), FDG-PET in 51.7% (46/89), F-DOPAPET in 57.1% (12/21), 131/123I-metaiodobenzylguanidine in 30.8% (4/13), and 68Gallium-SSTRPET/CT in 81.8% (18/22) of cases. Molecular imaging discovered 79.1% (53/67) of tumors unidentified by conventional radiology, with OCT the most commonly used, revealing the tumor in 64%, followed by FDG-PET in 59.4%. F-DOPA-PET was used in only seven covert cases (sensitivity, 85.7%). Notably, 68Gallium-SSTR-PET/CT had 100% sensitivity among covert cases. CONCLUSIONS: Nuclear medicine improves the sensitivity of conventional radiology when tumor site identification is problematic. OCT offers a good availability/reliability ratio, and FDG-PET was proven useful. 68Gallium-SSTR-PET/CT use was infrequent, despite offering the highest sensitivity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2015-1589

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 150

Metadata

Authors
Isidori, A. M., Sbardella, E., Zatelli, M. C., Boschetti, M., Vitale, G., Colao, A., Pivonello, R., * ABC (Altogether to Beat Cushing's syndrome) 2013 Group collaborators, Albiger, N., Ambrogio, A., Arnaldi, G., Arvat, E., Berardelli, R., Boscaro, M., Boschetti, M., Cannavò, S., Cavagnini, F., Colao, A., Corsello, S. M., Cozzolino, A., De Leo, M., Di Somma, C., Esposito, K., Ferone, D., Foresta, C., Gatto, F., Giordano, C., Giugliano, D., Graziadio, C., Isidori, A. M., Loli, P., Manetti, L., Mannelli, M., Marzullo, P., Mantero, F., Minuto, F., Paragliola, R. M., Giraldi, F. P., Pivonello, R., Reimondo, G., Scaroni, C., Scillitani, A., Simeoli, C., Stigliano, A., Terzolo, M., Tortora, F., Trementino, L., Vitale, G., & Zatelli, M. C.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2015-09
Volume
100
Issue
9
Pages
3231-3244
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2099366630
Cited by
150
References
3
FWCI
2.01
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.